Science topic
Adolescent Psychiatry - Science topic
The medical science that deals with the origin, diagnosis, prevention, and treatment of mental disorders in individuals 13-18 years.
Questions related to Adolescent Psychiatry
I have not found many studies about this treatment. It has been approved by FDA based on very preliminary evidence. How much time does FDA take in general to approve a treatment in mental health field?
I believe while doing research about depression we are doing a huge mistake. We often use screening tools for depression, such a self-reported scale (e.g. EURO-D), and those who are at risk are often called "depressed".
Being at high risk for depression does not mean being depressed.
I often read about incredibly high prevalence of depression in many studies, but then in the methods I see a screening tool was used to measure depressive symptoms.
Depression is not diagnosed in such a way.
Diagnosis of depression can be done only in a clinical setting.
While using scale for screening, we need to talk about "individuals at high risk for depression" or individuals with "high level of depressive symptoms".
It is like if we would refer to those with low tolerance to glucose as diabetic after asking them the value of glucose last time they made a blood test. Actually, this would be even more accurate.
What is your idea?
I agree with Michael Uebel that PHQ-9 is a useful screening tool, as well as other validated questionnaires (Zung's SDS, CES-D, HADS, Whooley, etc.). However, they are just screening tools, not diagnostic tools. A positive screening indicates that there is a likelihood of having a depressive disorder.
E.g., it is accepted that the operational features (sensitivity, specificity...) of the PHQ9 are sufficiently good to recommend its use as a screening tool, but its predictive positive value (at best: in a population with high prevalence of depression) could be around of 50 % (i. e., 50% of positive results in PHQ 9 do not have depression).
Please, read this old but interesting paper: https://www.researchgate.net/profile/Alex_Mitchell/publication/26703371
I'm doing a critical analysis test your knowledge report.
I wonder if different approaches are taken to using naso-gastric feeding in anorexia nervosa patients in different countries / clinics. I would like to hear about policies and practices in different places. Only because of somatic indications, which? Also because of psychological indications, which?
I could really use some adolescent-specific information on selective mutism. I am interested in therapy approaches, manuals, anecdotes, insights, whatever you've got.
Psychiatric Social Worker means social worker practicing in psychiatric field or mental health field.
A 20 year old male had suffered from mild head trauma. He had no neurological deficits and no investigations were carried out. Hours later he started stuttering when speaking and claims it is as a result of his head trauma. Stuttering has been present for 3 days. How can a doctor tell if it is true stuttering or the person is faking it.
Can anyone suggest a scale for measuring cognitive development in adolescence?
I developed a 25-item measure to assess callous-unemotional traits in adolescents. While the intended construct is not comprehensive as the YPI, it is somewhat similar to the YPI in that some items are phrased to have a higher valence of interest or appeal to adolescents, e.g., "It really doesn't bother me if someone gets shot or dies, unless it's my family or friend"; "I don't mean to sound cold, but I've got to think about myself first, that's just the way life is". This measure is written in American English. I am interested in finding researchers who could pilot this scale. If translated to another language, two or three items use colloquial expression and would require a very good translation.
Please contact me
In the last few years many prescribers do not prescribe IR-MPH in their practice, although clinical guidelines do not support this practice, especially in the titration phase. A pharmaceutical industry is very strong towards newer forms and atomoxetine, which is lower in term of efficacy (effect sizes obtained from meta-analyses). How IR-MPH should be used that patients with ADHD are treated more appropriate? Easy question but hard to answer.
A mixture of positive psychology/subject focused therapy and training in communication thru the format of empowerment.
I have read extensively of the proposed danger in this particular medication and would like statistics surrounding its adverse effects; also if comparisons to other mood stabilizers' side-effects are available, that would be great too. Thank you!
Does anyone know of validated instruments to measure a respondent's (a) attitudes, (b) perceptions, and/or (c) actual disclosure(s) of a psychiatric disability? I'm interested in when, why, with whom, and in what contexts individuals might choose to disclose - or not (understanding that perhaps these questions are best answered with qualitative data). And, relatedly, I'm thinking of investigating disclosure of mental illness among adolescents and emerging adults in academic settings.
We are developing an instrument to assess treatmet outcomes of substance abuse treatment of adolescents. We want to identify scales of famliy functioning to use them as a model for the family dimension in our measure.
I'm looking for an existing brief questionnaire or a screening tool to detect self-harming and suicide risk in a youth population exposed to traumatic experiences to be administered after their attendance to a forensic interview; a brief intervention would be needed as a subsequent strategy to prevent self-harming and suicide risk.
The therapeutic milieu has been central to residential child and adolescent mental health and other areas of mental health. The milieu facilitates the growth of healing and resilience by providing a nurturing environment in which clients can trust that they will be kept safe whilst they explore/work on both their strengths and needs until they feel confident enough to engage in coping with their issues and the challenges of everyday life experiences. Putting trust in others when feeling vulnerable is tough and can create difficult dynamics for staff, clients carers and impact on other extant systems with whom they interact. Staff need education and support to consistently work with clients and to use every moment to moment as an opportunity to tune into their client and offer the relevant balance of nurture and challenge to promote trust, a sense of autonomy, a sense of competence, a positive identity and the confidence to engage in relationships and cope with everyday challenges within their lived experiences. The aim of compassionate, client centred care , which is supported by wider systems in the creation of an safe, respectful, healing environment appears to resonates with current health care aims , highlighted for example in the UK by the Berwick report, the Francis report. Furthermore, to be successful, the therapeutic milieu has to work as a subsystem and liaise and collaborate with all other systems ( from family to community, education, housing social services) with whom the client/family interacts.
Given the wealth of research on the therapeutic milieu, to what extent do others feel/have experience in the transferability of the principles of therapeutic milieu research and literature to general wards e.g. wards caring for elderly vulnerable patients? Also, to what extent can the whole system approach of an effective milieu, (which responds to the interdependence of individual systems, family systems and wider community systems) be transferred to the current model of health as a complex, whole systems approach in which client and families require the support of a 'virtual' 24 hour life milieu in which the strengths and needs of each client at an individual, family and community level can be negotiated with the client, matched with a package of feasible health and social care ? Residential therapeutic care has been reduced globally in mental health because it is expensive . The creation of a virtual therapeutic milieu is a tough road. In your experience, is it/could it be therapeutically and cost effective?
Adherence and compliance in child and adolescent psychiatry are part of subjective pharmacology and closely linked to lay theories of psychiatric diseases. Since often clients and their parents to not stick to treatment plans I would appreciate suggestions concerning literature and future resarch projects
This is especially for suicidality. It is one of major issues when everyone speaks about public health burden of different mental disorders, as most important negative outcome. But in RCT-s this is one of the main exclusion criteria. It means that we have moderately ill people in RCT-s.
